Simcha Therapeutics
Simcha Therapeutics is a biotech company in New Haven, United States. It has raised $65.0M across 2 rounds, most recently a $40.0M Series B in 2022 (est.).
Pioneering Transformational Immunotherapies
- Headquarters
- New Haven, Connecticut
- Employees
- 11–50
- Business Model
- B2B
- Website
- simchatx.com
- Total Funding
- $65.0M
- Last Round
- $40.0M Series BJan 2022
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.
About
Simcha Therapeutics is a clinical-stage immunobiology company pioneering the development of first-in-class engineered cytokine therapeutics for cancer. The company's name derives from the Hebrew word for joy, reflecting its mission to advance medicines that bring hope to patients with cancer. Simcha focuses on transforming fundamental discoveries in immune biology into innovative drugs that promise more than incremental advances.
Summary
It lists 11–50 employees. It has raised $65.0M in total across 2 rounds, most recently a $40.0M Series B round in 2022 (est.). Investors include SR One, BVF Partners and Samsara BioCapital.
Funding History
2022 (est.)
Sign up to see all 2 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/simcha-therapeutics"><img src="https://indexed.vc/api/badge/company/simcha-therapeutics" alt="Simcha Therapeutics on Indexed.vc" width="260" height="76" /></a>